CHM 15.0% 1.7¢ chimeric therapeutics limited

Ann: CHM CDH17 Phase 1/2 clinical trial approved for initiation, page-18

  1. 11,983 Posts.
    lightbulb Created with Sketch. 6130
    @DrillDown2014
    @KrushingIt Appreciate you sharing the information from the presentation and providing your own personal views ,, looks undervalued from where I'm sitting ..thanks NZT
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.